Book Appointment

Ropinirole and Impulsive Behaviour: A Concern for Restless Leg Syndrome Patients

February 28th, 2025
shutterstock 192794273

By Dr Murli Krishna

Ropinirole, a medication commonly prescribed for restless leg syndrome (RLS), has recently come under scrutiny due to its potential to cause impulsive and compulsive behaviours in some patients. This dopamine agonist, while effective in treating RLS symptoms, may lead to unexpected and potentially harmful side effects that patients and healthcare providers should be aware of.

Understanding the Link

Ropinirole belongs to a class of drugs called dopamine agonists, which work by mimicking the effects of dopamine in the brain. While this mechanism helps alleviate RLS symptoms, it can also affect the brain’s reward system, potentially leading to impulse control disorders in some individuals.

Impulsive Behaviours Observed

Patients taking ropinirole for RLS have reported experiencing various impulsive and compulsive behaviours, including:

  • Compulsive gambling
  • Uncontrolled shopping
  • Binge eating
  • Hypersexuality
  • Hoarding

These behaviours can develop suddenly and may not be immediately recognised as medication side effects, potentially causing significant personal and financial distress.

Recent NHS Claims

The National Health Service (NHS) in the UK has recently highlighted the risk of impulsive and compulsive behaviours associated with ropinirole. According to the NHS, some people may experience these side effects while taking therapeutic doses of the medication1. The NHS advises patients to be aware of potential changes in behaviour and to report any concerns to their healthcare provider promptly.

There have been recent cases of legal action related to impulsive behaviour caused by Ropinirole, including claims against the NHS. Here are some key details:

  • In December 2024, Philip Stevens, a 66-year-old man from Hampshire, received a £70,000 settlement from his GP after developing an uncontrollable gambling problem due to taking Ropinirole.
  • Stevens was prescribed Ropinirole for restless leg syndrome in 2017 but was not warned about the potential side effects, including impulse control disorders.
  • The NHS lists impulse control disorder as a potential side effect of Ropinirole. Patients are advised to contact a specialist nurse if they start “binge eating, gambling or shopping uncontrollably or having an unusually high sex drive”.
  • Stevens experienced severe compulsive behaviours, including uncontrollable gambling, shopping for expensive clothes, and going on frequent fishing trips.
  • In another case from May 2023, a 51-year-old probation officer (referred to as Janet) settled a claim against her GP for prescribing Ropinirole without warning her about the risks. She suffered from impulse control issues that cost her over £70,000 in gambling and excess spending.

These cases highlight the serious consequences of Ropinirole-induced impulsive behaviour and the importance of proper patient education about potential side effects. The NHS and healthcare providers are facing increased scrutiny and legal action due to the lack of adequate warnings about these risks.

Prevalence and Risk Factors

Research suggests that the prevalence of impulse control disorders in patients treated with dopamine agonists like ropinirole can be significant. One study found that up to 25% of patients taking ropinirole for Parkinson’s disease experienced such behaviours. While the prevalence in RLS patients may differ, the risk remains a concern.

Managing the Risk

If you’re taking ropinirole for RLS and experience any unusual urges or behavioural changes, it’s crucial to:

  • Speak to your healthcare provider immediately
  • Do not stop taking the medication abruptly without medical advice
  • Consider dose adjustment or medication changes under professional guidance

Healthcare providers may consider alternative treatments or careful monitoring to balance symptom control with minimising the risk of impulsive behaviours.

How can patients ensure they receive proper warnings about medication side effects?

To ensure proper warnings about medication side effects, patients can take several proactive steps:

Ask questions during consultations: When your doctor prescribes a new medication, ask specifically about potential side effects, their likelihood, and what to do if you experience them.

  • Request a Patient Information Leaflet: These leaflets provide detailed information on dosage, common side effects, and special warnings. If you don’t receive one, ask your healthcare provider or download it from the Medicines and Healthcare Products Regulatory Agency website.
  • Discuss benefits and risks: Engage your doctor in a conversation about the benefits and risks of the prescribed medication. They should explain why they’re prescribing it and provide an overview of possible side effects.
  • Seek clarification: If you don’t understand the information provided, ask your doctor to explain it again. They should ensure you comprehend the details before leaving the consultation.
  • Use online resources: Access reliable sources like NHS.UK for additional information about your medication.
  • Consult your pharmacist: When collecting your prescription, discuss the medication with the pharmacist. They can provide additional information and reinforce proper usage.
  • Report any issues: If you experience side effects, report them through the Yellow Card scheme. This helps authorities monitor medication safety.
  • Regular medication reviews: Schedule regular appointments with your healthcare provider to review your medications, especially if you’re taking multiple drugs.
  • Utilize technology: If available, sign up for online access to your medical records and prescription services, which may provide additional information about your medications.

How can patients access reliable sources of information about medication side effects?

Patients can access reliable sources of information about medication side effects through several channels:

  • Patient Information Leaflets (PILs): These are comprehensive documents provided with medications that detail potential side effects, dosage information, and other important details. PILs are widely used and easily accessible, though some patients may find them less trustworthy than other sources.
  • General Practitioners (GPs): GPs are one of the most frequently used and trusted sources for medication information. Patients should ask their GPs about potential side effects during consultations.
  • Pharmacists: Although underutilised, pharmacists are considered both easily accessible and trustworthy. Patients can consult them when collecting prescriptions for additional information about side effects.
  • NHS.UK: This is the UK’s largest public-facing health website, designed as a ‘one-stop’ online resource for patients in England. It provides reliable information on various health topics, including medication side effects.
  • Electronic Medicines Compendium (EMC): This website hosts manufacturer-provided patient information leaflets, which include detailed information about side effects.
  • British National Formulary (BNF): While primarily designed for healthcare professionals, the BNF provides clear and consistent information about medicines, including side effects.

Conclusion

While ropinirole remains an effective treatment for restless leg syndrome, patients and healthcare providers must be vigilant about the potential for impulsive and compulsive behaviours. Open communication, regular check-ups, and awareness of these possible side effects are essential for the safe and effective management of RLS symptoms.

Remember, not everyone taking ropinirole will experience these side effects, but awareness and prompt action, if they do occur, can prevent potentially serious consequences. Always consult with your healthcare provider about any concerns or changes in behaviour while taking this medication.